Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana

Recent clinical trials have shown that a daily dose of oral TDF/FTC pre-exposure prophylaxis (PrEP) is effective in reducing human immunodeficiency (HIV) risk. Understanding trial participants’ perspectives about retention and PrEP adherence is critical to inform future PrEP trials and the scale-up...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J AIDS
Main Authors: Toledo, Lauren, McLellan-Lemal, Eleanor, Henderson, Faith L., Kebaabetswe, Poloko M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4708891/
https://ncbi.nlm.nih.gov/pubmed/26767149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4236/wja.2015.51002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados